Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-07 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-07 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-08 |